向IGF2重新编程瘤微环境,以加强病毒免疫疗法
Min Hye Noh1, Jin Muk Kang1,2, Alexandra A Miller3,1
1Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Neuro-oncology
|June 10, 2024
概括
瘤性简单性疹病毒-1 (oHSV) 治疗显示出有希望的结果,但面临阻力. 这项研究揭示了IGF2作为一种关键的耐药性因素,一种新型oHSV变种 (oHSV-D11mt) 克服了这一局限性,改善了癌症免疫疗法.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫治疗是一种免疫疗法.
背景情况:
- 型疹简单病毒-1 (oHSV) 治疗是一种有前途的癌症免疫疗法,已获得FDA批准.
- 然而,它的有效性受到许多患者的瘤和瘤微环境 (TME) 耐药性的限制.
研究的目的:
- 识别有助于oHSV耐药性的分子标.
- 阐明基质瘤和乳腺癌大脑转移 (BCBM) 模型中对oHSV治疗产生抗性的机制.
主要方法:
- 使用RNA测序 (RNA-Seq) 来识别耐药性标.
- 用内质瘤和BCBM的小鼠模型来研究oHSV耐药机制.
主要成果:
- 鉴定出IGF2是oHSV治疗后升调的关键分泌蛋白,也在复发性GBM患者中观察到.
- 削弱IGF2增强了oHSV的瘤杀伤能力,并在体内改善了生存率.
- 一种新的oHSV变种oHSV-D11mt,分泌IGF2R域11 (IGF2RD11mt),有效地阻断了IGF2,增加了细胞毒性并增强了抗瘤免疫反应.
结论:
- 这项研究首次报告说,分泌的IGF2在oHSV耐药性中起着关键作用.
- 新型oHSV-D11mt变种代表了克服oHSV耐药性和增强病毒免疫治疗的有前途的治疗进展.
更多相关视频
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
14.7K
10:03Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
9.8K
相关概念视频
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:30Cancer Vaccines
354
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
354
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K